載入...
Tocilizumab in the treatment of twelve cases with aa amyloidosis secondary to familial mediterranean fever
BACKGROUND: There is no established treatment of AA amyloidosis, a long-term complication of various chronic inflammatory diseases associated with increased mortality, such as familial Mediterranian fever (FMF). Recently there are few reports pointing out that tocilizumab(TCZ), an anti IL-6 agent ma...
Na minha lista:
| 發表在: | Orphanet J Rare Dis |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5450086/ https://ncbi.nlm.nih.gov/pubmed/28558744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-017-0642-0 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|